{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:29:11Z","timestamp":1778628551355,"version":"3.51.4"},"reference-count":129,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1053\/j.semnuclmed.2004.03.007","type":"journal-article","created":{"date-parts":[[2004,6,17]],"date-time":"2004-06-17T17:07:49Z","timestamp":1087492069000},"page":"224-240","source":"Crossref","is-referenced-by-count":45,"title":["Current and future uses of positron emission tomography in breast cancer imaging"],"prefix":"10.1053","volume":"34","author":[{"given":"William B","family":"Eubank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Mankoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","article-title":"Cancer Statistics, 2000","volume":"50","author":"Greenlee","year":"2000","journal-title":"CA Cancer J Clin"},{"issue":"suppl 12","key":"10.1053\/j.semnuclmed.2004.03.007_BIB2","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/1097-0142(20000615)88:12+<3073::AID-CNCR26>3.0.CO;2-R","article-title":"Developments in chemotherapy of breast cancer","volume":"88","author":"Hortobagyi","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB3","first-page":"2578","article-title":"Pathological assessment of response to induction chemotherapy in breast cancer","volume":"46","author":"Feldman","year":"1986","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB4","first-page":"125","article-title":"Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma","volume":"4","author":"Machiavelli","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB5","first-page":"56","article-title":"Salvage chemotherapy for metastatic breast cancer","volume":"24","author":"Hortobagyi","year":"1987","journal-title":"Semin Hematol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB6","series-title":"Important Advances in Oncology","first-page":"103","article-title":"Hormonal manipulation in the adjuvant treatment of breast cancer","author":"Honig","year":"1993"},{"issue":"12 Suppl","key":"10.1053\/j.semnuclmed.2004.03.007_BIB7","first-page":"4350s","article-title":"Prospects for combining hormonal and nonhormonal growth factor inhibition","volume":"7","author":"Wakeling","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/BF00240671","article-title":"Monitoring tumor response","volume":"6","author":"Husband","year":"1996","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB9","series-title":"The Basic Science of Oncology","author":"Tannock","year":"1992"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1148\/radiology.179.3.2027989","article-title":"Primary and metastatic breast carcinoma","volume":"179","author":"Wahl","year":"1991","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB11","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1002\/1097-0142(19930615)71:12<3920::AID-CNCR2820711220>3.0.CO;2-N","article-title":"Positron emission tomography with [fluorine-18]-deoxyglucose in the detection and staging of breast cancer","volume":"71","author":"Nieweg","year":"1993","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0748-7983(95)91492-7","article-title":"Positron emission tomography","volume":"21","author":"Bruce","year":"1995","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000658-199207000-00005","article-title":"The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease","volume":"216","author":"Tse","year":"1992","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiology.187.3.8497624","article-title":"Evaluation of breast masses and axillary lymph nodes with [F-18]-2-deoxy-2-fluoro-D-glucose PET","volume":"187","author":"Adler","year":"1993","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00004728-199307000-00012","article-title":"Cancer detection with whole-body PET using 2-[F-18]-fluoro-2-deoxy-D-glucose","volume":"17","author":"Hoh","year":"1993","journal-title":"J Comput Assist Tomog"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB16","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.1996.14.6.1848","article-title":"Metabolic characterization of breast tumors with positron emission tomography using [F-18]-fluorodeoxyglucose","volume":"14","author":"Avril","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB17","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","article-title":"Breast imaging with positron emission tomography and [fluorine-18]-fluorodeoxyglucose","volume":"18","author":"Avril","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002590000448","article-title":"[F-18]-2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer","volume":"28","author":"Schirrmeister","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF00834522","article-title":"Qualitative [18F]-FDG positron emission tomography in primary breast cancer","volume":"23","author":"Scheidhauer","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB20","first-page":"90","article-title":"Large-core breast biopsy offers reliable diagnosis","volume":"12","author":"Parker","year":"1990","journal-title":"Diagnostic Imaging"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1148\/radiology.196.1.7784554","article-title":"Staging of suspected breast cancer","volume":"196","author":"Orel","year":"1995","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/BF00843710","article-title":"Preliminary results for positron emission mammography","volume":"23","author":"Weinberg","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB23","first-page":"1851","article-title":"Results of preliminary clinical trials of the positron emission mammography system PEM-I","volume":"41","author":"Murthy","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1148\/radiology.215.1.r00ap03280","article-title":"Positron emission mammographic instrument","volume":"215","author":"Murthy","year":"2000","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB25","first-page":"594","article-title":"Are we ready for dedicated breast imaging approaches?","volume":"44","author":"Mankoff","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s002590050319","article-title":"Association between [18F]-fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer","volume":"25","author":"Crippa","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB27","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W","article-title":"Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose","volume":"82","author":"Oshida","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB28","first-page":"9","article-title":"Glucose metabolism of breast cancer assessed by 18F-FDG-PET","volume":"42","author":"Avril","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.20.2.379","article-title":"Biologic correlates of [18F]-fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography","volume":"20","author":"Bos","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB30","first-page":"500","article-title":"Blood flow and metabolism in locally advanced breast cancer (LABC)","volume":"43","author":"Mankoff","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB31","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00259-002-0880-8","article-title":"FDG uptake in breast cancer","volume":"29","author":"Buck","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB32","first-page":"1766","article-title":"Positron tomographic assessment of estrogen receptors in breast cancer","volume":"36","author":"Dehdashti","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB33","first-page":"4","article-title":"Prospective evaluation of [fluorine-18]-FDG-PET in presurgical staging of the axilla in breast cancer","volume":"39","author":"Crippa","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB34","first-page":"16","article-title":"Defining apoptosis","volume":"146","author":"Hockenberry","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1022494613613","article-title":"Aberrant glycolytic metabolism of cancer cells","volume":"29","author":"Mathapala","year":"1997","journal-title":"J Bioenerg Biomembr"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/A:1022498714522","article-title":"Aerobic glycosis by proliferating cells","volume":"29","author":"Brand","year":"1997","journal-title":"J Bioenerg Biomembr"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB37","first-page":"5680","article-title":"Bcl-xL prevents the initial disease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis","volume":"20","author":"Gottleib","year":"2000","journal-title":"MolCell Biol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1368-7646(02)00120-6","article-title":"Activation of the PI3K\/Akt pathway and chemotherapeutic resistance","volume":"6","author":"West","year":"2002","journal-title":"Drug Resist Updat"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.neo.7900075","article-title":"Characterizing tumors using metabolic imaging","volume":"2","author":"Mankoff","year":"2000","journal-title":"Neoplasia"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(96)00325-2","article-title":"Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]-fluoromisonidazole","volume":"36","author":"Rasey","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1148\/radiology.203.2.9114082","article-title":"Axillary lymph node metastases","volume":"203","author":"Adler","year":"1997","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB42","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/BF01249621","article-title":"Prospective evaluation of [fluorine-18]-fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry","volume":"23","author":"Utech","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB43","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/88.17.1204","article-title":"Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-[fluorine-18]-fluoro-2-deoxy-D-glucose","volume":"88","author":"Avril","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00000658-199808000-00012","article-title":"Staging of the axilla in breast cancer","volume":"228","author":"Smith","year":"1998","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB45","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/93.8.630","article-title":"Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography","volume":"93","author":"Greco","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB46","first-page":"77P","article-title":"Prospective multi-center study of axillary nodal staging with FDG positron emission tomography in breast cancer","volume":"44","author":"Wahl","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/1097-0142(19940201)73:3<664::AID-CNCR2820730326>3.0.CO;2-S","article-title":"Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?","volume":"73","author":"Silverstein","year":"1994","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1055-3207(18)30198-4","article-title":"The significance of breast cancer lymph node micrometastases","volume":"8","author":"Yeatman","year":"1999","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB49","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.1996.03540220042028","article-title":"Lymphatic mapping and sentinel node biopsy in the patient with breast cancer","volume":"276","author":"Albertini","year":"1996","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1245\/ASO.2003.12.019","article-title":"Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer","volume":"10","author":"Barranger","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB51","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000658-200211000-00012","article-title":"Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer","volume":"236","author":"van der Hoeven","year":"2002","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1013828710301","article-title":"Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose","volume":"71","author":"Guller","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jjco\/hye007","article-title":"Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients","volume":"31","author":"Yang","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3816\/CBC.2002.n.014","article-title":"Positron emission tomography and sentinel lymph node dissection in breast cancer","volume":"3","author":"Kelemen","year":"2002","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB55","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.1999.17.5.1508","article-title":"Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy","volume":"17","author":"Wagner","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB56","first-page":"34P","article-title":"Economic analysis of sentinel-node surgery versus preoperative FDG-PET in the management of patients with intermediate thickness cutaneous melanomas","volume":"38","author":"Wojcik","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB57","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2214\/ajr.171.4.9763005","article-title":"Imaging of oncologic patients","volume":"171","author":"Eubank","year":"1998","journal-title":"AJR"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB58","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.2000.18.15.2817","article-title":"Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy","volume":"18","author":"Katz","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB59","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1148\/radiology.210.3.r99mr43807","article-title":"The value of combined FDG-PET and magnetic resonance imaging in the evaluation of suspected recurrent local-regional breast cancer","volume":"210","author":"Hathaway","year":"1998","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB60","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/sj.bjc.6690074","article-title":"Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients","volume":"79","author":"Ahmad","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB61","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/1097-0142(197702)39:2<533::AID-CNCR2820390222>3.0.CO;2-V","article-title":"The influence of untreated internal mammary metastases upon the course of mammary cancer","volume":"39","author":"Donegan","year":"1977","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02303699","article-title":"Internal mammary node status","volume":"2","author":"Cody","year":"1995","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB63","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF02523652","article-title":"Should internal mammary nodes be sampled in the sentinel lymph node era?","volume":"7","author":"Sugg","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB64","unstructured":"Bellon JR, Gralow JR, Livingston RB, et al: Evaluation of the internal mammary (IM) lymph nodes by FDG-PET in locally advanced breast cancer (LABC). Am J Clinical Oncol (in press)"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB65","first-page":"289P","article-title":"Assessment of internal mammary lymph nodes by fluorodeoxyglucose positron emission (FDG-PET) in medial hemisphere breast cancer","volume":"41","author":"Bernstein","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB66","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1200\/JCO.1998.16.6.2142","article-title":"Lymph node staging in non-small-cell lung cancer with FDG-PET scan","volume":"16","author":"Vansteenkiste","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB67","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-5223(96)70317-3","article-title":"Mediastinal lymph node staging of non-small-cell lung cancer","volume":"111","author":"Scott","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB68","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1200\/JCO.2001.19.15.3516","article-title":"18Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer","volume":"19","author":"Eubank","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB69","first-page":"431","article-title":"Accuracy of whole-body [fluorine-18]-FDG-PET for the detection of recurrent or metastatic breast carcinoma","volume":"39","author":"Moon","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB70","first-page":"1687","article-title":"Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma","volume":"17","author":"Bender","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1095-0397(00)00042-X","article-title":"The place of whole-body PET FDG for the diagnosis of distant recurrence of breast cancer","volume":"3","author":"Lonneux","year":"2000","journal-title":"Clinical Positron Imaging"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB72","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s002680020095","article-title":"Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer","volume":"25","author":"Kim","year":"2001","journal-title":"World J Surg"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB73","first-page":"1859","article-title":"The value of positron emission tomography in the follow-up for breast cancer","volume":"23","author":"Siggelkow","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB74","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1019664126220","article-title":"The role of 18F-FDG-PET in the local\/regional evaluation of women with breast cancer","volume":"75","author":"Danforth","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB75","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00432-003-0424-z","article-title":"[18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer","volume":"129","author":"Kamel","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB76","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jjco\/hyf052","article-title":"Clinical impact of [18F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels","volume":"32","author":"Liu","year":"2002","journal-title":"Jpn J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB77","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.RLI.0000063983.86229.f2","article-title":"F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma","volume":"38","author":"Gallowitsch","year":"2003","journal-title":"Invest Radiol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB78","first-page":"113","article-title":"Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers","volume":"46","author":"Suarez","year":"2002","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB79","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1148\/radiographics.22.1.g02ja055","article-title":"Detection of locoregional and distant recurrences in breast cancer patients by using FDG-PET","volume":"22","author":"Eubank","year":"2002","journal-title":"Radiographics"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB80","first-page":"325","article-title":"Whole-body 18F-FDG-PET and conventional imaging for predicting outcome in previously treated breast cancer patients","volume":"43","author":"Vranjesevic","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB81","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1991.9.3.509","article-title":"Bone metastases","volume":"9","author":"Nielsen","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB82","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","article-title":"Detection of bone metastases in breast cancer by 18FDG-PET","volume":"16","author":"Cook","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB83","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.1999.17.8.2381","article-title":"Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography","volume":"17","author":"Schirrmeister","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB84","first-page":"1800","article-title":"Prospective evaluation of the clinical value of planar bone scans, SPECT, and [18]F-labeled NaF PET in newly diagnosed lung cancer","volume":"42","author":"Schirrmeister","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB85","first-page":"1334","article-title":"Impact of whole-body 18FDG-PET on staging and managing patients with breast cancer","volume":"42","author":"Yap","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB86","doi-asserted-by":"crossref","DOI":"10.2214\/ajr.183.2.1830479","article-title":"Impact of [F-18]-Fluorodeoxyglucose PET on defining the extent of disease and management of patients with recurrent or metastatic breast cancer","author":"Eubank","year":"2004","journal-title":"AJR"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB87","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1148\/radiology.198.2.8596826","article-title":"Locally advanced breast carcinoma","volume":"198","author":"Helvie","year":"1996","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB88","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1993.11.11.2101","article-title":"Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography","volume":"11","author":"Wahl","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB89","first-page":"931","article-title":"Evaluation of preoperative chemotherapy using PET with [fluorine-18]-fluorodeoxyglucose in breast cancer","volume":"37","author":"Bassa","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB90","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.1995.13.6.1470","article-title":"Positron emission tomography studies in patients with locally advanced and\/or metastatic breast cancer","volume":"13","author":"Jansson","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB91","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2000.18.8.1689","article-title":"Positron emission tomography using [18F]-fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer","volume":"18","author":"Schelling","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB92","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1200\/JCO.2000.18.8.1676","article-title":"Positron emission tomography using [18F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/09553009114551621","article-title":"Haemodynamic and transport barriers to the treatment of solid tumors","volume":"60","author":"Jain","year":"1991","journal-title":"Int J Radiat Biol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB94","first-page":"1806","article-title":"Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy","volume":"44","author":"Mankoff","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB95","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3816\/CBC.2000.n.014","article-title":"Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients","volume":"1","author":"Gennari","year":"2000","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB96","first-page":"1748","article-title":"Flare on bone scintigraphy following taxol chemotherapy for metastatic breast cancer","volume":"35","author":"Schneider","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB97","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1200\/JCO.1995.13.5.1123","article-title":"Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer","volume":"13","author":"Vogel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB98","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1076-6332(03)80461-0","article-title":"Use of serial FDG-PET to measure the response of bone-dominant breast cancer to therapy","volume":"9","author":"Stafford","year":"2001","journal-title":"Acad Radiol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB99","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2001.19.11.2797","article-title":"Metabolic flare","volume":"19","author":"Mortimer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB100","series-title":"The Basic Science of Oncology","article-title":"Cell proliferation","author":"Tannock","year":"1992"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB101","first-page":"43","article-title":"Thymidine metabolism and cell kinetics","volume":"6","author":"Cleaver","year":"1967","journal-title":"Frontiers Biol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB102","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.pa.17.040177.002525","article-title":"The clinical applications of cell kinetics in cancer therapy","volume":"17","author":"Livingston","year":"1977","journal-title":"Annu Rev Toxicol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB103","first-page":"1757","article-title":"[Carbon-11]-thymidine and FDG to measure therapy response","volume":"39","author":"Shields","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB104","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/3337","article-title":"Imaging proliferation in vivo with [F-18]FLT and positron emission tomography","volume":"4","author":"Shields","year":"1998","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0969-8051(99)00104-3","article-title":"Radiosynthesis of 3\u2032-deoxy-3\u2032-[(18)F]fluorothymidine","volume":"27","author":"Grierson","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB106","first-page":"3315","article-title":"In vivo validation of 3\u2032deoxy-3\u2032-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans","volume":"8","author":"Vesselle","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB107","first-page":"76P","article-title":"PET with fluoro-L-thymidine allows early prediction of breast cancer response to chemotherapy","volume":"44","author":"Pio","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB108","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/028418698430278","article-title":"Tumor hypoxia and gene expression\u2014implications for malignant progression and therapy","volume":"37","author":"Sutherland","year":"1998","journal-title":"Acta Oncol"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB109","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00689633","article-title":"Hypoxia and drug resistance","volume":"13","author":"Teicher","year":"1994","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB110","series-title":"Tumor Hypoxia. Stuttgart, Wissenschaftliche Veragsgesellschaft mbH","first-page":"1","article-title":"Oxygenation status of breast cancer","author":"Vaupel","year":"1999"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB111","first-page":"502","article-title":"Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells","volume":"37","author":"Clavo","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB112","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/1078-0432.CCR-0688-3","article-title":"Hypoxia and glucose metabolism in malignant tumors","volume":"10","author":"Rajendran","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB113","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0360-3016(89)90146-6","article-title":"Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia","volume":"17","author":"Rasey","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB114","series-title":"Positron Emission Tomography","first-page":"689","article-title":"Imaging tumor hypoxia","author":"Rajendran","year":"2002"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB115","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.168640","article-title":"Predicting response to endocrine therapy in human breast cancer","volume":"189","author":"McGuire","year":"1975","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0065-230X(08)60187-6","article-title":"Steroid hormone receptors in human breast cancer","volume":"38","author":"Sledge","year":"1983","journal-title":"Adv Cancer Res"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB117","first-page":"413","article-title":"Multiple estrogen receptor assays in human breast cancer","volume":"43","author":"Hull","year":"1983","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB118","first-page":"7057","article-title":"Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer","volume":"50","author":"Reiner","year":"1990","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB119","first-page":"1573","article-title":"The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer","volume":"17","author":"Katzenellenbogen","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB120","first-page":"765","article-title":"18F-labeled difluoroestrodiols","volume":"67","author":"Seimbelle","year":"2002","journal-title":"Steroids"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB121","first-page":"1212","article-title":"Preparation of four fluorine-18-labeled estrogens and their selective uptakes in target tissue of immature rats","volume":"25","author":"Kiesewetter","year":"1984","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB122","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1148\/radiology.169.1.3262228","article-title":"Breast cancer","volume":"169","author":"Mintun","year":"1988","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB123","first-page":"287P","article-title":"Factors affecting the level and heterogeneity of uptake of [18F]Fluoroestradiol (FES) in patients with estrogen receptor positive (ER+) breast cancer","volume":"43","author":"Mankoff","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB124","first-page":"1526","article-title":"Positron tomographic assessment of 16alpha-[F-18]-fluoro-17beta-estradiol uptake in metastatic breast carcinoma","volume":"32","author":"McGuire","year":"1991","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB125","first-page":"679","article-title":"[18F]-fluoroestradiol radiation dosimetry in human PET studies","volume":"42","author":"Mankoff","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB126","first-page":"6","article-title":"Non-invasive PET imaging of ER expression in breast cancer","volume":"42","author":"Mankoff","year":"2001","journal-title":"Proc AACR"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB127","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(81)91341-6","article-title":"Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy","volume":"1","author":"Campbell","year":"1981","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s002590050359","article-title":"Positron emission tomographic assessment of \u201cmetabolic flare\u201d to predict response of metastatic breast cancer to antiestrogen therapy","volume":"26","author":"Dehdashti","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.03.007_BIB129","first-page":"126P","article-title":"Uptake of [F-18]-Fluoroestradiol (FES) predicts response of recurrent or metastatic breast cancer to hormonal therapy","volume":"44","author":"Mankoff","year":"2003","journal-title":"J Nucl Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000129980400025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000129980400025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T12:49:28Z","timestamp":1585831768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000129980400025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S000129980400025X"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2004.03.007","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}